Genetic Testing (PGT/PGD) in Guwahati: What Every Couple Needs to Know Before IVF

Preimplantation Genetic Testing (PGT) is a laboratory procedure performed on embryos created during an IVF cycle. A tiny biopsy — usually of 5-8 cells — is taken from the trophectoderm (the outer layer of a blastocyst-stage embryo) and sent to a specialist genetics laboratory. The embryo itself remains frozen while results are awaited, ensuring it is not harmed during analysis.

There are three main types: PGT-A (aneuploidy screening, formerly PGS) checks for the correct number of chromosomes; PGT-M (monogenic disorders) tests for specific inherited conditions such as thalassaemia, sickle cell disease, or spinal muscular atrophy; and PGT-SR (structural rearrangements) identifies translocations or inversions in parental chromosomes.

For couples in Guwahati, particularly those with a family history of thalassaemia — which is notably prevalent across Assam and Northeast India — PGT-M is especially clinically relevant. By selecting only unaffected embryos for transfer, couples can break the cycle of a hereditary condition before it begins. The HomeIVF Medical Board recommends genetic counselling before any PGT cycle to ensure patients fully understand which test type is appropriate for their specific clinical situation.

Not every couple undergoing IVF requires PGT, but for certain clinical profiles it is a strongly evidence-backed recommendation. The HomeIVF Medical Board identifies the following as priority candidates for genetic testing discussion during consultation:

Women over 35 years of age face a significantly higher risk of producing aneuploid (chromosomally abnormal) embryos. Couples who have experienced two or more consecutive miscarriages — sometimes called recurrent pregnancy loss or RPL — often find that chromosomal abnormalities in embryos are the underlying cause. Patients who have undergone two or more failed IVF transfers despite good-quality embryos are another key group.

In Guwahati specifically, communities with a known high carrier frequency of beta-thalassaemia — including populations across the Brahmaputra valley — benefit enormously from PGT-M testing, which can confirm an embryo is unaffected before implantation. Similarly, couples where one partner carries a chromosomal translocation identified during karyotyping should strongly consider PGT-SR.

Men with severe oligospermia (very low sperm count) also produce embryos with higher rates of chromosomal error, making PGT-A a reasonable addition to their IVF cycle. HomeIVF counsellors based across Guwahati's residential zones — including clients from Beltola and Zoo Road — help couples evaluate their specific risk profile before committing to testing.

Understanding each stage of the PGT journey removes anxiety and helps couples plan realistically. Here is the clinical pathway as coordinated by HomeIVF for patients in Guwahati and surrounding Assam districts.

Step 1 — Genetic Counselling: Before the IVF cycle begins, a senior genetic counsellor reviews the couple's medical history, karyotype reports, and family pedigree. This session, which HomeIVF facilitates via tele-consult or in-person coordination, determines which PGT type is needed and whether a probe preparation phase is required (mandatory for PGT-M).

Step 2 — Ovarian Stimulation and Egg Retrieval: The female partner undergoes a standard IVF stimulation protocol monitored via ultrasound and hormone tests. HomeIVF coordinates home-based hormone monitoring for patients in areas like Dispur, reducing travel load during the stimulation phase.

Step 3 — Embryo Culture to Blastocyst: Fertilised eggs are cultured for 5-6 days in the laboratory until they reach the blastocyst stage, which is optimal for biopsy.

Step 4 — Trophectoderm Biopsy: A few cells are removed from the outer layer of each blastocyst by an embryologist under microscope. All biopsied embryos are immediately vitrified (flash-frozen).

Step 5 — Genetic Analysis: Biopsied cells are dispatched to an accredited genetics lab. Results are available in 10-14 working days.

Step 6 — Frozen Embryo Transfer: Only chromosomally normal or disease-free embryos are thawed and transferred in a subsequent cycle, significantly improving implantation prospects.

Assam and the Northeast Indian region carry a distinct genetic disease burden that makes PGT not just an optional add-on but a clinically vital tool for many families. The HomeIVF Medical Board prioritises awareness of the following conditions among Guwahati patients.

Beta-Thalassaemia Major is perhaps the most pressing concern. Assam has one of the highest carrier frequencies of thalassaemia in India, and couples where both partners are carriers face a one-in-four chance of having an affected child with each pregnancy. PGT-M eliminates this risk by identifying and selecting only unaffected embryos.

Sickle Cell Disease also shows elevated carrier rates across tribal and certain non-tribal communities in Assam. PGT-M testing for sickle cell is well-established and highly accurate when a probe has been prepared in advance.

Down Syndrome (Trisomy 21) and other chromosomal aneuploidies are screened via PGT-A. While Down syndrome itself is not inherited per se, older maternal age and paternal chromosomal rearrangements increase risk, and PGT-A provides a clear chromosomal picture of each embryo before transfer.

Chromosomal Translocations: Carriers of balanced translocations often appear healthy but produce a high proportion of abnormal embryos, leading to serial miscarriages. PGT-SR can identify the structurally normal embryos within a cohort, restoring hope for couples who have suffered repeated losses in Guwahati and surrounding districts like Kamrup Metropolitan.

HomeIVF brings a coordinated, senior-specialist-led approach to fertility care that is particularly valuable for patients in Guwahati, where subspecialty genetics services have historically required travel to Kolkata, Bengaluru, or Delhi.

The HomeIVF model integrates tele-genetic counselling, home-based monitoring, and partnerships with NABL-accredited genetics laboratories to create a seamless PGT pathway. Patients from Beltola, Zoo Road, Six Mile, and Dispur have accessed HomeIVF services without having to take extended leave from work or family responsibilities.

Home-based cycle monitoring is a core HomeIVF advantage. During ovarian stimulation, trained nurses visit the patient's home to collect blood samples for hormone assays (AMH, FSH, E2, LH) and coordinate with sonography centres nearby for follicle tracking scans. This data is reviewed daily by the HomeIVF Medical Board, who adjust medication protocols in real time — the same rigorous oversight a patient would receive at a tier-1 IVF clinic, delivered locally.

For PGT-M cases requiring probe preparation (a 4-8 week process before IVF can begin), HomeIVF counsellors proactively manage timelines so patients are not surprised by delays. IVF packages starting from ₹1.5 lakh are available through HomeIVF, with PGT add-ons priced transparently based on the number of embryos biopsied and the test type selected.

One of the most common questions HomeIVF counsellors receive from Guwahati patients is: 'How long will this take?' Setting honest expectations is central to the HomeIVF philosophy.

A PGT-A cycle, when no prior preparation is needed, typically spans 6-10 weeks from the start of stimulation to embryo transfer. This includes the stimulation phase (10-14 days), blastocyst culture (5-6 days), genetic analysis (10-14 working days), a hormone preparation phase for frozen embryo transfer (2-3 weeks), and then the transfer itself.

A PGT-M cycle is longer because probe preparation — designing a unique genetic test specific to the couple's mutation — takes 4-8 weeks before IVF stimulation even begins. Couples with known thalassaemia carrier status in Guwahati are strongly advised to initiate this process as early as possible, ideally 2-3 months before they wish to start their IVF cycle.

Embryo numbers matter significantly. Couples who produce only 1-2 blastocysts may find that all embryos are chromosomally abnormal, necessitating another stimulation cycle. Statistical modelling by the HomeIVF Medical Board suggests that women under 38 with 4-6 blastocysts available have a high probability of identifying at least one euploid embryo suitable for transfer.

Success rates after PGT-A-selected frozen embryo transfer in India typically range from 50-65% per transfer cycle, compared to 40-55% for non-selected transfers, making PGT a meaningful clinical investment for the right candidate.

Despite Guwahati being Northeast India's largest city, couples seeking advanced reproductive genetics face real structural barriers. Awareness remains low — many gynaecologists in smaller Assam towns have limited exposure to PGT referral pathways, meaning couples often discover these options only after years of failed treatment. HomeIVF addresses this by providing a direct, accessible first-consultation model that does not require a specialist referral.

Language and cultural comfort are also relevant. HomeIVF's Guwahati-linked counsellors are familiar with Assamese and Bengali-speaking patient needs, and consultations can be conducted in the patient's preferred language. For families in conservative households — including many in the Dispur and Beltola residential belts — the ability to receive counselling and early monitoring at home removes stigma and privacy concerns associated with visiting a fertility clinic.

Accredited genetics labs that can process PGT samples are not yet established within Guwahati itself. HomeIVF maintains logistics partnerships with labs in Bengaluru, Mumbai, and Hyderabad that meet international quality standards, with cold-chain sample transport protocols ensuring sample integrity — a barrier that individual patients cannot solve on their own.

Financially, HomeIVF's transparent pricing model and EMI options help Guwahati families budget for PGT without the surprise costs that are common in unregulated fertility markets. The HomeIVF Medical Board reviews every case to ensure PGT is being recommended for clinically valid reasons, not unnecessarily upsold.

Consider a composite case representative of several HomeIVF patients from Assam: a couple in their early thirties from the Zoo Road area of Guwahati, both identified as beta-thalassaemia carriers during routine premarital screening. After consulting their local gynaecologist, they were told natural conception carried a 25% risk per pregnancy of producing a child with thalassaemia major — a condition requiring lifelong blood transfusions.

Through HomeIVF, they were connected with a senior reproductive geneticist via tele-consult within 48 hours. Probe preparation was initiated immediately, and four weeks later their IVF stimulation cycle began with home-based monitoring coordinated from their Guwahati residence. The egg retrieval and embryo culture were performed at a partner clinic. Six blastocysts were biopsied; PGT-M results identified two embryos as unaffected and suitable for transfer.

A single frozen embryo transfer was performed six weeks later. The couple received a positive pregnancy test 12 days post-transfer, confirmed as unaffected by thalassaemia through chorionic villus sampling at 11 weeks.

This pathway — from first HomeIVF consultation to positive pregnancy — took approximately 20 weeks. It required no relocation to a metro city and was managed with clear communication at every stage. This is precisely the standard of care HomeIVF is committed to delivering across Guwahati and the wider Northeast India region.